Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 817 to 823 of 823 entries
Sorted by: Best Match Show Resources per page
CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical

Bhan A, Jacobsen C, Dalen I, Bergsland N, Zivadinov R, Alves G, Myhr KM, Farbu E.
PMID: 34900328
Mult Scler J Exp Transl Clin. 2021 Dec 06;7(4):20552173211060337. doi: 10.1177/20552173211060337. eCollection 2021 Oct.

BACKGROUND: Neurofilament light chain (NfL) is an attractive biomarker of disease activity and progression in MS, but there is a lack in long-term prognostic data.OBJECTIVE: To test the long-term clinical and radiological prognostic value of cerebrospinal fluid (CSF)-NfL among...

Cite
Bhan A, Jacobsen C, Dalen I, et al. CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis. Mult Scler J Exp Transl Clin. 2021;7(4):20552173211060337doi: 10.1177/20552173211060337.
Bhan, A., Jacobsen, C., Dalen, I., Bergsland, N., Zivadinov, R., Alves, G., Myhr, K. M., & Farbu, E. (2021). CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical, 7(4), 20552173211060337. https://doi.org/10.1177/20552173211060337
Bhan, Alok, et al. "CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis." Multiple sclerosis journal - experimental, translational and clinical vol. 7,4 (2021): 20552173211060337. doi: https://doi.org/10.1177/20552173211060337
Bhan A, Jacobsen C, Dalen I, Bergsland N, Zivadinov R, Alves G, Myhr KM, Farbu E. CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis. Mult Scler J Exp Transl Clin. 2021 Dec 06;7(4):20552173211060337. doi: 10.1177/20552173211060337. eCollection 2021 Oct. PMID: 34900328; PMCID: PMC8652913.
Copy Download .nbib Format: NLM
Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception Cohort.

Arthritis & rheumatology (Hoboken, N.J.)

Hanly JG, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Urowitz MB, Bruce IN, Petri M, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jonsen A, Alarcón GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Farewell V.
PMID: 34042329
Arthritis Rheumatol. 2021 Dec;73(12):2293-2302. doi: 10.1002/art.41876. Epub 2021 Oct 29.

OBJECTIVE: To determine predictors of change in neuropsychiatric (NP) event status in a large, prospective, international inception cohort of patients with systemic lupus erythematosus (SLE).METHODS: Upon enrollment and annually thereafter, NP events attributed to SLE and non-SLE causes and...

Cite
Hanly JG, Gordon C, Bae SC, et al. Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception Cohort. Arthritis Rheumatol. 2021;73(12):2293-2302doi: 10.1002/art.41876.
Hanly, J. G., Gordon, C., Bae, S. C., Romero-Diaz, J., Sanchez-Guerrero, J., Bernatsky, S., Clarke, A. E., Wallace, D. J., Isenberg, D. A., Rahman, A., Merrill, J. T., Fortin, P. R., Gladman, D. D., Urowitz, M. B., Bruce, I. N., Petri, M., Ginzler, E. M., Dooley, M. A., Ramsey-Goldman, R., Manzi, S., Jonsen, A., Alarcón, G. S., van Vollenhoven, R. F., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Lim, S. S., Inanc, M., Kalunian, K. C., Jacobsen, S., Peschken, C. A., Kamen, D. L., Askanase, A., & Farewell, V. (2021). Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception Cohort. Arthritis & rheumatology (Hoboken, N.J.), 73(12), 2293-2302. https://doi.org/10.1002/art.41876
Hanly, John G, et al. "Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception Cohort." Arthritis & rheumatology (Hoboken, N.J.) vol. 73,12 (2021): 2293-2302. doi: https://doi.org/10.1002/art.41876
Hanly JG, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Urowitz MB, Bruce IN, Petri M, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jonsen A, Alarcón GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Farewell V. Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception Cohort. Arthritis Rheumatol. 2021 Dec;73(12):2293-2302. doi: 10.1002/art.41876. Epub 2021 Oct 29. PMID: 34042329; PMCID: PMC8626529.
Copy Download .nbib Format: NLM
The National Cancer Institute's Role in Advancing Health-Care Delivery Research.

Journal of the National Cancer Institute

Jacobsen PB, de Moor J, Doria-Rose VP, Geiger AM, Kobrin SC, Sampson A, Smith AW.
PMID: 33993284
J Natl Cancer Inst. 2022 Jan 11;114(1):20-24. doi: 10.1093/jnci/djab096.

Improvements in cancer care delivery have the potential to reduce morbidity and mortality from cancer, however, challenges to delivery of recommended care limit progress. These challenges include growing demands for care, increasing treatment complexity, inadequate care coordination, dramatic increases...

Cite
Jacobsen PB, de Moor J, Doria-Rose VP, et al. The National Cancer Institute's Role in Advancing Health-Care Delivery Research. J Natl Cancer Inst. 2022;114(1):20-24doi: 10.1093/jnci/djab096.
Jacobsen, P. B., de Moor, J., Doria-Rose, V. P., Geiger, A. M., Kobrin, S. C., Sampson, A., & Smith, A. W. (2022). The National Cancer Institute's Role in Advancing Health-Care Delivery Research. Journal of the National Cancer Institute, 114(1), 20-24. https://doi.org/10.1093/jnci/djab096
Jacobsen, Paul B, et al. "The National Cancer Institute's Role in Advancing Health-Care Delivery Research." Journal of the National Cancer Institute vol. 114,1 (2022): 20-24. doi: https://doi.org/10.1093/jnci/djab096
Jacobsen PB, de Moor J, Doria-Rose VP, Geiger AM, Kobrin SC, Sampson A, Smith AW. The National Cancer Institute's Role in Advancing Health-Care Delivery Research. J Natl Cancer Inst. 2022 Jan 11;114(1):20-24. doi: 10.1093/jnci/djab096. PMID: 33993284.
Copy Download .nbib Format: NLM
FLNC-Associated Myofibrillar Myopathy: New Clinical, Functional, and Proteomic Data.

Neurology. Genetics

Kley RA, Leber Y, Schrank B, Zhuge H, Orfanos Z, Kostan J, Onipe A, Sellung D, Güttsches AK, Eggers B, Jacobsen F, Kress W, Marcus K, Djinovic-Carugo K, van der Ven PFM, Fürst DO, Vorgerd M.
PMID: 34235269
Neurol Genet. 2021 May 18;7(3):e590. doi: 10.1212/NXG.0000000000000590. eCollection 2021 Jun.

OBJECTIVE: To determine whether a new indel mutation in the dimerization domain of filamin C (FLNc) causes a hereditary myopathy with protein aggregation in muscle fibers, we clinically and molecularly studied a German family with autosomal dominant myofibrillar myopathy...

Cite
Kley RA, Leber Y, Schrank B, et al. FLNC-Associated Myofibrillar Myopathy: New Clinical, Functional, and Proteomic Data. Neurol Genet. 2021;7(3):e590doi: 10.1212/NXG.0000000000000590.
Kley, R. A., Leber, Y., Schrank, B., Zhuge, H., Orfanos, Z., Kostan, J., Onipe, A., Sellung, D., Güttsches, A. K., Eggers, B., Jacobsen, F., Kress, W., Marcus, K., Djinovic-Carugo, K., van der Ven, P. F. M., Fürst, D. O., & Vorgerd, M. (2021). FLNC-Associated Myofibrillar Myopathy: New Clinical, Functional, and Proteomic Data. Neurology. Genetics, 7(3), e590. https://doi.org/10.1212/NXG.0000000000000590
Kley, Rudolf Andre, et al. "FLNC-Associated Myofibrillar Myopathy: New Clinical, Functional, and Proteomic Data." Neurology. Genetics vol. 7,3 (2021): e590. doi: https://doi.org/10.1212/NXG.0000000000000590
Kley RA, Leber Y, Schrank B, Zhuge H, Orfanos Z, Kostan J, Onipe A, Sellung D, Güttsches AK, Eggers B, Jacobsen F, Kress W, Marcus K, Djinovic-Carugo K, van der Ven PFM, Fürst DO, Vorgerd M. FLNC-Associated Myofibrillar Myopathy: New Clinical, Functional, and Proteomic Data. Neurol Genet. 2021 May 18;7(3):e590. doi: 10.1212/NXG.0000000000000590. eCollection 2021 Jun. PMID: 34235269; PMCID: PMC8237399.
Copy Download .nbib Format: NLM
DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma.

Molecular cancer

Wu Q, Luo X, Terp MG, Li Q, Li Y, Shen L, Chen Y, Jacobsen K, Bivona TG, Chen H, Zeng R, Ditzel HJ.
PMID: 34446021
Mol Cancer. 2021 Aug 26;20(1):108. doi: 10.1186/s12943-021-01403-w.

BACKGROUND: Early recurrence is a major obstacle to prolonged postoperative survival in squamous cell lung carcinoma (SqCLC). The molecular mechanisms underlying early SqCLC recurrence remain unclear, and effective prognostic biomarkers for predicting early recurrence are needed.METHODS: We analyzed primary...

Cite
Wu Q, Luo X, Terp MG, et al. DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma. Mol Cancer. 2021;20(1):108doi: 10.1186/s12943-021-01403-w.
Wu, Q., Luo, X., Terp, M. G., Li, Q., Li, Y., Shen, L., Chen, Y., Jacobsen, K., Bivona, T. G., Chen, H., Zeng, R., & Ditzel, H. J. (2021). DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma. Molecular cancer, 20(1), 108. https://doi.org/10.1186/s12943-021-01403-w
Wu, Qingqing, et al. "DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma." Molecular cancer vol. 20,1 (2021): 108. doi: https://doi.org/10.1186/s12943-021-01403-w
Wu Q, Luo X, Terp MG, Li Q, Li Y, Shen L, Chen Y, Jacobsen K, Bivona TG, Chen H, Zeng R, Ditzel HJ. DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma. Mol Cancer. 2021 Aug 26;20(1):108. doi: 10.1186/s12943-021-01403-w. PMID: 34446021; PMCID: PMC8393456.
Copy Download .nbib Format: NLM
Cost-effectiveness and value of information analysis of multiple frequency bioimpedance devices for fluid management in people with chronic kidney disease having dialysis.

Cost effectiveness and resource allocation : C/E

Jacobsen E, Cruickshank M, Cooper D, Marks A, Brazzelli M, Scotland G.
PMID: 33902602
Cost Eff Resour Alloc. 2021 Apr 26;19(1):24. doi: 10.1186/s12962-021-00276-6.

BACKGROUND: Among people with chronic kidney disease (CKD) on dialysis, sub-optimal fluid management has been linked with hospitalisation, cardiovascular complications and death. This study assessed the cost-effectiveness using multiple-frequency bioimpedance guided fluid management versus standard fluid management based on...

Cite
Jacobsen E, Cruickshank M, Cooper D, et al. Cost-effectiveness and value of information analysis of multiple frequency bioimpedance devices for fluid management in people with chronic kidney disease having dialysis. Cost Eff Resour Alloc. 2021;19(1):24doi: 10.1186/s12962-021-00276-6.
Jacobsen, E., Cruickshank, M., Cooper, D., Marks, A., Brazzelli, M., & Scotland, G. (2021). Cost-effectiveness and value of information analysis of multiple frequency bioimpedance devices for fluid management in people with chronic kidney disease having dialysis. Cost effectiveness and resource allocation : C/E, 19(1), 24. https://doi.org/10.1186/s12962-021-00276-6
Jacobsen, Elisabet, et al. "Cost-effectiveness and value of information analysis of multiple frequency bioimpedance devices for fluid management in people with chronic kidney disease having dialysis." Cost effectiveness and resource allocation : C/E vol. 19,1 (2021): 24. doi: https://doi.org/10.1186/s12962-021-00276-6
Jacobsen E, Cruickshank M, Cooper D, Marks A, Brazzelli M, Scotland G. Cost-effectiveness and value of information analysis of multiple frequency bioimpedance devices for fluid management in people with chronic kidney disease having dialysis. Cost Eff Resour Alloc. 2021 Apr 26;19(1):24. doi: 10.1186/s12962-021-00276-6. PMID: 33902602; PMCID: PMC8077940.
Copy Download .nbib Format: NLM
Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors.

Human pathology

Menz A, Bauer R, Kluth M, Marie von Bargen C, Gorbokon N, Viehweger F, Lennartz M, Völkl C, Fraune C, Uhlig R, Hube-Magg C, De Wispelaere N, Minner S, Sauter G, Kind S, Simon R, Burandt E, Clauditz T, Lebok P, Jacobsen F, Steurer S, Wilczak W, Krech T, Marx AH, Bernreuther C.
PMID: 34102222
Hum Pathol. 2021 Sep;115:19-36. doi: 10.1016/j.humpath.2021.05.012. Epub 2021 Jun 06.

To evaluate cytokeratin 19 (CK19) expression in normal and cancerous tissues, 15,977 samples from 122 tumor types and 608 samples of 76 normal tissue types were analyzed by immunohistochemistry (IHC). In normal tissues, CK19 expression occurred in epithelial cells...

Cite
Menz A, Bauer R, Kluth M, et al. Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors. Hum Pathol. 2021;115:19-36doi: 10.1016/j.humpath.2021.05.012.
Menz, A., Bauer, R., Kluth, M., Marie von Bargen, C., Gorbokon, N., Viehweger, F., Lennartz, M., Völkl, C., Fraune, C., Uhlig, R., Hube-Magg, C., De Wispelaere, N., Minner, S., Sauter, G., Kind, S., Simon, R., Burandt, E., Clauditz, T., Lebok, P., Jacobsen, F., Steurer, S., Wilczak, W., Krech, T., Marx, A. H., & Bernreuther, C. (2021). Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors. Human pathology, 11519-36. https://doi.org/10.1016/j.humpath.2021.05.012
Menz, Anne, et al. "Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors." Human pathology vol. 115 (2021): 19-36. doi: https://doi.org/10.1016/j.humpath.2021.05.012
Menz A, Bauer R, Kluth M, Marie von Bargen C, Gorbokon N, Viehweger F, Lennartz M, Völkl C, Fraune C, Uhlig R, Hube-Magg C, De Wispelaere N, Minner S, Sauter G, Kind S, Simon R, Burandt E, Clauditz T, Lebok P, Jacobsen F, Steurer S, Wilczak W, Krech T, Marx AH, Bernreuther C. Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors. Hum Pathol. 2021 Sep;115:19-36. doi: 10.1016/j.humpath.2021.05.012. Epub 2021 Jun 06. PMID: 34102222.
Copy Download .nbib Format: NLM
Showing 817 to 823 of 823 entries